readthroughSign in
CompanyCADLNasdaqNeedham, MA

Candel Therapeutics, Inc.

Candel develops off-the-shelf multimodal immunotherapies using genetically modified adenovirus and herpes simplex virus constructs.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story